| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07b71571160c289fbf5fc680dfea513f |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12 |
| filingDate |
1998-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e9129cc5567ad75c8245f8a4b574f5c |
| publicationDate |
2000-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CZ-20001060-A3 |
| titleOfInvention |
Vitronectin receptor antagonist |
| abstract |
Described is a compound of formula (I) or a pharmaceutically acceptable salt thereofnan acceptable salt that is a vitronectin receptor antagonist and isnsuitable for the treatment of osteoporosis. |
| priorityDate |
1998-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |